Published in Cancer Weekly, October 24th, 2000
"If the extent of surgery can be reduced without compromising the survival of the patient, then both society and the patients will benefit," comment chief researcher Gabriella Cohn-Cedermark, MD, PhD, and colleagues from the Department of Oncology and Pathology at Karolinska Hospital in Stockholm, Sweden.
No differences in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.